טוען...
Alzheimer's disease progression model based on integrated biomarkers and clinical measures
AIM: Biomarkers and image markers of Alzheimer's disease (AD), such as cerebrospinal fluid Aβ(42) and p-tau, are effective predictors of cognitive decline or dementia. The aim of this study was to integrate these markers with a disease progression model and to identify their abnormal ranges. ME...
שמור ב:
| Main Authors: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Nature Publishing Group
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4155529/ https://ncbi.nlm.nih.gov/pubmed/25088003 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/aps.2014.57 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|